Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc. is experiencing robust growth, particularly in its industrial injury prevention business, which has shown exceptional momentum in recent quarters. The company's financial guidance indicates an increase in adjusted EBITDA expectations for FY/25, now projected between $93 million to $97 million, reflecting an approximate 8.6% growth compared to the previous year. Additionally, the anticipated growth rates of 17.1% and 10.0% in different revenue segments suggest strong operational performance and a positive outlook for the company's financial trajectory.

Bears say

US Physical Therapy Inc. faces ongoing challenges due to its reliance on managed care programs and Medicare, which may affect its pricing power moving forward despite the anticipated absence of pricing headwinds in 2026. The company's revenue generation primarily stems from its Physical therapy operations segment, which is susceptible to fluctuations in reimbursement rates from commercial health insurance and government programs, raising concerns about revenue stability. Additionally, the broader economic climate and potential regulatory changes within the healthcare sector could further impact the company's financial performance and future growth prospects.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Apr 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $104.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $104.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.